{'fraction_non_alphanumeric': 0.044444444444444446, 'fraction_numerical': 0.012865497076023392, 'mean_word_length': 6.016393442622951, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Synthesis and Characterizations of Macroporous Poly(acrylamide-2-acrylamido-2-methyl-1-propanesulfonic acid) Hydrogels for In Vitro Drug Release of Ranitidine Hydrochloride

Macroporous hydrogels were prepared with acrylamide (AM) and 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS) as well as with anhydrous dextrose (AD) as porogen by crosslinking with N,N1-methylenebisacrylamide (MBA). The chemical structure of hydrogels is characterized by Fourier transform infrared (FTIR) spectroscopy. Morphological studies done by scanning electron microscopy (SEM) showed the macroporous nature of the hydrogels. Swelling studies of hydrogels were done in distilled water, in aqueous NaCl solution and in different pH solutions. In addition, drug release studies of selected macroporous hydrogels (DAMPS1, DAMPS4, DAMPSM1 and DAMPSM3) are also investigated.